RU2001108716A - METHOD FOR TREATING PERSONS SUFFERING FROM SEPSIS - Google Patents
METHOD FOR TREATING PERSONS SUFFERING FROM SEPSISInfo
- Publication number
- RU2001108716A RU2001108716A RU2001108716/14A RU2001108716A RU2001108716A RU 2001108716 A RU2001108716 A RU 2001108716A RU 2001108716/14 A RU2001108716/14 A RU 2001108716/14A RU 2001108716 A RU2001108716 A RU 2001108716A RU 2001108716 A RU2001108716 A RU 2001108716A
- Authority
- RU
- Russia
- Prior art keywords
- necrosis factor
- tumor necrosis
- sepsis
- persons suffering
- administered
- Prior art date
Links
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 6
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 claims 6
- 230000003042 antagnostic Effects 0.000 claims 3
- 239000005557 antagonist Substances 0.000 claims 3
- 102000005614 monoclonal antibodies Human genes 0.000 claims 2
- 108010045030 monoclonal antibodies Proteins 0.000 claims 2
- 229940100601 Interleukin-6 Drugs 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 102000003298 Tumor Necrosis Factor Receptors Human genes 0.000 claims 1
- 108060008683 Tumor Necrosis Factor Receptors Proteins 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
Claims (4)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4403669.8 | 1994-02-07 | ||
DE4403669 | 1994-02-07 | ||
DEP4409513.9 | 1994-03-19 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96118134/14A Division RU96118134A (en) | 1994-02-07 | 1995-01-27 | APPLICATION OF ANTIBODIES AGAINST THE TUMOR NECROSIS FACTOR AS A MEDICINE FOR THE TREATMENT OF DISEASES CONNECTED WITH AN INCREASED INTERLEUKIN-6 IN SERUM |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2197990C2 RU2197990C2 (en) | 2003-02-10 |
RU2001108716A true RU2001108716A (en) | 2004-04-20 |
Family
ID=6509608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001108716/14A RU2197990C2 (en) | 1994-02-07 | 1995-01-27 | Method for treating sepsis-suffering patients |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR100414505B1 (en) |
DE (2) | DE4409513C1 (en) |
RU (1) | RU2197990C2 (en) |
UA (1) | UA46731C2 (en) |
ZA (1) | ZA95956B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3631229A1 (en) * | 1986-09-13 | 1988-03-24 | Basf Ag | MONOCLONAL ANTIBODIES AGAINST HUMAN TUMORNESCROSE FACTOR (TNF) AND THEIR USE |
AU648777B2 (en) * | 1989-12-04 | 1994-05-05 | Schering Corporation | Method of treating septic shock |
-
1994
- 1994-03-19 DE DE4409513A patent/DE4409513C1/en not_active Expired - Fee Related
-
1995
- 1995-01-27 KR KR1019960704289A patent/KR100414505B1/en not_active IP Right Cessation
- 1995-01-27 UA UA96093469A patent/UA46731C2/en unknown
- 1995-01-27 DE DE59510625T patent/DE59510625D1/en not_active Expired - Fee Related
- 1995-01-27 RU RU2001108716/14A patent/RU2197990C2/en not_active IP Right Cessation
- 1995-02-07 ZA ZA95956A patent/ZA95956B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0783893B1 (en) | Inhibition of abnormal growth of synovial cells using il-6 antagonist as active ingredient | |
CA2261630C (en) | Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease | |
US8017121B2 (en) | Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component | |
HUT76875A (en) | Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels | |
US20020176858A1 (en) | Monoclonal antibodies to TGF-BETA | |
CA2089229A1 (en) | Cd40cr receptor and ligands therefor | |
NO20051048L (en) | Therapeutic human anti-IL-1R1 monoclonal antibody | |
HUP9802483A3 (en) | Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease | |
DE69724451D1 (en) | COMBINATION THERAPY WITH A TNF-BINDING PROTEIN FOR TREATING DISEASES CAUSED BY TNF | |
CA2290021A1 (en) | Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy | |
WO1995019570B1 (en) | Antagonists to insulin receptor tyrosine kinase inhibitor | |
Hansen et al. | Influence of interleukin‐6 (IL‐6) autoantibodies on IL‐6 binding to cellular receptors | |
RU2004137823A (en) | THERAPEUTIC AGAINST HYPERCALCEMIC CRISIS | |
CA2364026A1 (en) | Anti-tnf.alpha. antibodies in therapy of asthma | |
BG103416A (en) | Soluble lymphotoxin-beta receptors, antilymphotosoluble lymphotoxin- receptors, antilymphotoxin receptor antibodies and antilymphotoxin ligand antixin receptor antibodies and antilymphotoxin ligandbodies as therapeutical forms for the treatment of antibodies as therapeutical forms for the treatment of immunological diseases immunological diseases | |
EP0525570A2 (en) | Anti-idiotypic antibodies that mimic TNF | |
CA2002144A1 (en) | Method of preventing or reducing eosinophilia | |
RU2001108716A (en) | METHOD FOR TREATING PERSONS SUFFERING FROM SEPSIS | |
FI922551A (en) | FOERFARANDE FOER SKOETSEL AV SEPTISK CHOCK. | |
Marusić-Galesić et al. | Cellular immune response to the antigen administered as an immune complex. | |
Koyama et al. | Effect of chemical modification of antigen on characteristics of immune complexes and their glomerular localization in the murine renal tissues. | |
DE69630761D1 (en) | METHOD FOR REDUCING THE RENAL ENTRANCE OF ANTIBODY FRAGMENTS | |
RU2000112873A (en) | APPLICATION OF ANTAGONISTS OF THE TUMOR NECROSIS FACTOR FOR THE PRODUCTION OF MEDICINES FOR THE TREATMENT OF SEPTIC DISEASES | |
RU2197990C2 (en) | Method for treating sepsis-suffering patients | |
AU732764B2 (en) | Rheumatoid arthritis remedy containing IL-6 antagonist as effective component |